[go: up one dir, main page]

FI902632A0 - Menetelmä terapeuttisesti käyttökelpoisten 5-substitoitujen 5,11-dihydrodibentso/b,e//1,4/tiatsepiinijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 5-substitoitujen 5,11-dihydrodibentso/b,e//1,4/tiatsepiinijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita

Info

Publication number
FI902632A0
FI902632A0 FI902632A FI902632A FI902632A0 FI 902632 A0 FI902632 A0 FI 902632A0 FI 902632 A FI902632 A FI 902632A FI 902632 A FI902632 A FI 902632A FI 902632 A0 FI902632 A0 FI 902632A0
Authority
FI
Finland
Prior art keywords
useful
dihydrodibenzo
substituted
preparation
intermediates
Prior art date
Application number
FI902632A
Other languages
English (en)
Swedish (sv)
Other versions
FI96950B (fi
FI96950C (fi
Inventor
David Alker
Peter Edward Cross
Robert John Bass
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI902632A0 publication Critical patent/FI902632A0/fi
Publication of FI96950B publication Critical patent/FI96950B/fi
Application granted granted Critical
Publication of FI96950C publication Critical patent/FI96950C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI902632A 1989-05-27 1990-05-25 Menetelmä terapeuttisesti käyttökelpoisten 5-substitoitujen 5,11-dihydrodibentso/b,e//1,4/tiatsepiinijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita FI96950C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898912303A GB8912303D0 (en) 1989-05-27 1989-05-27 Therapeutic agents
GB8912303 1989-05-27

Publications (3)

Publication Number Publication Date
FI902632A0 true FI902632A0 (fi) 1990-05-25
FI96950B FI96950B (fi) 1996-06-14
FI96950C FI96950C (fi) 1996-09-25

Family

ID=10657526

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902632A FI96950C (fi) 1989-05-27 1990-05-25 Menetelmä terapeuttisesti käyttökelpoisten 5-substitoitujen 5,11-dihydrodibentso/b,e//1,4/tiatsepiinijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita

Country Status (20)

Country Link
US (1) US5071844A (fi)
EP (1) EP0404359B1 (fi)
JP (1) JPH0317079A (fi)
KR (1) KR900018091A (fi)
CN (1) CN1047673A (fi)
AT (1) ATE107927T1 (fi)
AU (1) AU5595490A (fi)
CA (1) CA2017535C (fi)
DD (1) DD294718A5 (fi)
DE (1) DE69010285T2 (fi)
DK (1) DK0404359T3 (fi)
ES (1) ES2055867T3 (fi)
FI (1) FI96950C (fi)
GB (1) GB8912303D0 (fi)
HU (1) HUT58329A (fi)
IE (1) IE64196B1 (fi)
IL (1) IL94457A0 (fi)
NO (1) NO902336L (fi)
PL (1) PL285350A1 (fi)
PT (1) PT94151B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057513A (en) * 1989-05-25 1991-10-15 Fujisawa Pharmaceutical Co., Ltd. Spiro-thiazepine derivatives useful as paf antagonists
IT1247509B (it) * 1991-04-19 1994-12-17 Univ Cagliari Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
US5437291A (en) * 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
TW479057B (en) * 1996-03-11 2002-03-11 Ajinomoto Kk 5,11-dihydrobenzo[b,e] [1,4]oxazepine derivatives and pharmaceutical composition containing the same
WO1999012925A1 (en) * 1997-09-10 1999-03-18 Ajinomoto Co., Inc. 5,11-DIHYDRODIBENZ[b,e][1,4]OXAZEPINE DERIVATIVES AND MEDICINAL COMPOSITION CONTAINING THE SAME
ATE224366T1 (de) 1997-10-31 2002-10-15 Hoffmann La Roche D-prolinderivate
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
HUP0102935A3 (en) 1998-06-03 2002-01-28 Gpi Nil Holdings Inc Wilmingto N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres and pharmaceutical compositions containing them
EP1142884A4 (en) * 1999-01-08 2002-06-12 Ajinomoto Kk OXAZEPINE DERIVATIVES AND MEDICAMENTS CONTAINING SUCH DERIVATIVES
EP1219611A4 (en) * 1999-09-03 2003-03-19 Ajinomoto Kk NEW PROCESSES FOR THE PRODUCTION OF OXAZEPINE DERIVATIVES
EP1403258A4 (en) 2001-05-30 2005-06-08 Ajinomoto Kk DIHYDRODIARY LOXAZEPINE DERIVATIVE AND A DERIVATIVE MEDICAL COMPOSITION
JP2005343791A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc 消化管疾患を治療するための医薬組成物
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
WO2011016576A1 (en) 2009-08-04 2011-02-10 Takeda Pharmaceutical Company Limited Alanine derivatives as inhibitors of apoptosis proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB988008A (fi) * 1900-01-01
GB774882A (en) * 1954-06-21 1957-05-15 Rhone Poulenc Sa Improvements in or relating to phenthiazine derivatives
GB975705A (en) * 1960-04-14 1964-11-18 Westminster Bank Ltd Improvements in or relating to the preparation of 3-alkylmercapto phenothiazines and intermediates formed in the process
CH407127A (de) * 1962-02-19 1966-02-15 Geigy Ag J R Verfahren zur Herstellung von N-heterocyclischen Verbindungen
US3188322A (en) * 1962-08-08 1965-06-08 Olin Mathieson Dihydrodibenzothiazepines

Also Published As

Publication number Publication date
JPH057389B2 (fi) 1993-01-28
IE901883L (en) 1990-11-27
PT94151A (pt) 1991-01-08
DD294718A5 (de) 1991-10-10
PT94151B (pt) 1996-12-31
EP0404359A1 (en) 1990-12-27
FI96950B (fi) 1996-06-14
KR900018091A (ko) 1990-12-20
DE69010285D1 (de) 1994-08-04
PL285350A1 (en) 1991-05-20
AU5595490A (en) 1990-11-29
EP0404359B1 (en) 1994-06-29
CN1047673A (zh) 1990-12-12
GB8912303D0 (en) 1989-07-12
US5071844A (en) 1991-12-10
FI96950C (fi) 1996-09-25
DE69010285T2 (de) 1994-10-13
CA2017535C (en) 2000-02-29
DK0404359T3 (da) 1994-07-25
ATE107927T1 (de) 1994-07-15
IL94457A0 (en) 1991-06-10
NO902336L (no) 1990-11-28
JPH0317079A (ja) 1991-01-25
HUT58329A (en) 1992-02-28
HU903197D0 (en) 1990-10-28
NO902336D0 (no) 1990-05-25
IE64196B1 (en) 1995-07-12
ES2055867T3 (es) 1994-09-01
CA2017535A1 (en) 1990-11-27

Similar Documents

Publication Publication Date Title
ES2088537T3 (es) Derivados de piranil cianoguanidina.
FI902632A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-substitoitujen 5,11-dihydrodibentso/b,e//1,4/tiatsepiinijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita
GR3036455T3 (en) Atherosclerosis treatment
PT98362A (pt) Processo para a preparacao de derivados de tioalquiltio-cefalosporina e de composicoes farmaceuticas que os contem
PT87361A (pt) Process for preparing dihydropyridines
EP0632031A4 (fi)
AU5795694A (en) New bicyclic nitrogen compounds, process for preparing them and pharmaceutical compositions containing them
EP0604354A3 (en) Antidepressant and anti-Parkinson's disease compounds.
PT1468692E (pt) Utilizacao de 2,6-dialquil-4-sililfenois para o tratamento do xantoma
DE3673688D1 (de) Succinimide derivate, herstellung und anwendung.
DE69512310D1 (de) Glukopyranosid-Benzothiophene
DK0489379T3 (da) 5-Amino-5,6,7,8-tetrahydroquinoliner og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendels
DE3889993D1 (de) 2'-Deoxy-5-fluorouridin-Derivate.
TW275629B (fi)
ES497823A0 (es) Un procedimiento para la preparacion de derivados de tirosi-na.
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: PFIZER INC.